Skip to content

Meta-Analysis on the Usefulness of B-D-Glucan Testing in Intraocular Fluids for the Diagnosis of Fungal Endophthalmitis

B-D-Glucan in Intraocular Fluids for Fungal Endophthalmitis: A Meta-Analysis of Diagnostic Test Accuracy - Meta-Analysis of B-D-Glucan for Fungal Endophthalmitis Diagnosis

Status
Active, not recruiting
Phases
Unknown
Study type
Unknown
Source
JPRN
Registry ID
JPRN-UMIN000056075
Enrollment
Unknown
Registered
2024-11-06
Start date
2024-11-06
Completion date
Unknown
Last updated
2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Fungal Endophthalmitis

Interventions

None listed

Sponsors

Yokohama City University
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: Included studies will be case-control, cross-sectional, prospective, or retrospective clinical studies that provide sufficient data on both the sensitivity and specificity of BDG for FE. Original studies must provide sufficient data to calculate at least one of AUC-ROC, DOR, or combined sensitivity and specificity of BDG for diagnosing fungal endophthalmitis. The reference standard is a clinical diagnosis by a physician, and the specimens included in the study will be aqueous humor and vitreous fluid. Sensitivity is defined as the number of true positives divided by the sum of true positives and false negatives, while specificity is defined as the number of true negatives divided by the sum of true negatives and false positives. No age restrictions will be imposed, nor will there be restrictions on publication date. No language restrictions will apply if sufficient data is provided. Both full-length articles and brief reports will be included.

Exclusion criteria

Exclusion criteria: Studies reporting only sensitivity or specificity will be excluded, as this precludes conducting a bivariate meta-analysis. Duplication of data will be avoided and duplicate use will be excluded.

Design outcomes

Primary

MeasureTime frame
Sensitivity, specificity, area under the curve (AUC), and diagnostic odds ratio (DOR) will be evaluated. If a study includes a range of cut-offs, the data point closest to the widely used cut-off of 20 pg/mL for serum BDG on a log scale will be selected for analysis.

Countries

Japan

Contacts

Public ContactYuki Mizuki

Yokohama City University School of Medicine Department of Ophthalmology and Visual Science

mizuki.yuk.xj@yokohama-cu.ac.jp81-45-787-2683

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026